Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 4 studies | 22% ± 4% | |
fibroblast | 4 studies | 24% ± 7% | |
monocyte | 3 studies | 30% ± 9% | |
myeloid cell | 3 studies | 29% ± 7% |
Insufficient scRNA-seq data for expression of EGR2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 82% | 1483.07 | 534 / 653 | 94% | 63.29 | 570 / 605 |
lung | 89% | 906.46 | 517 / 578 | 86% | 15.66 | 989 / 1155 |
breast | 83% | 1035.87 | 380 / 459 | 89% | 21.70 | 999 / 1118 |
prostate | 70% | 491.82 | 172 / 245 | 87% | 24.26 | 439 / 502 |
skin | 75% | 1132.97 | 1354 / 1809 | 78% | 14.10 | 367 / 472 |
brain | 32% | 215.53 | 858 / 2642 | 82% | 25.45 | 575 / 705 |
ovary | 41% | 273.25 | 73 / 180 | 71% | 11.13 | 305 / 430 |
uterus | 42% | 271.38 | 71 / 170 | 62% | 9.04 | 285 / 459 |
bladder | 48% | 385.14 | 10 / 21 | 53% | 7.47 | 268 / 504 |
pancreas | 10% | 38.33 | 33 / 328 | 88% | 22.09 | 156 / 178 |
esophagus | 32% | 188.23 | 468 / 1445 | 65% | 14.72 | 119 / 183 |
lymph node | 0% | 0 | 0 / 0 | 97% | 32.87 | 28 / 29 |
intestine | 46% | 237.04 | 443 / 966 | 50% | 7.55 | 265 / 527 |
stomach | 35% | 212.26 | 124 / 359 | 60% | 7.80 | 171 / 286 |
kidney | 35% | 194.11 | 31 / 89 | 58% | 10.22 | 521 / 901 |
tonsil | 0% | 0 | 0 / 0 | 80% | 17.32 | 36 / 45 |
adrenal gland | 26% | 141.12 | 66 / 258 | 48% | 10.47 | 110 / 230 |
adipose | 73% | 771.48 | 883 / 1204 | 0% | 0 | 0 / 0 |
spleen | 72% | 326.13 | 173 / 241 | 0% | 0 | 0 / 0 |
heart | 67% | 999.36 | 574 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 52% | 342.22 | 696 / 1335 | 0% | 0 | 0 / 0 |
liver | 24% | 109.46 | 55 / 226 | 23% | 2.09 | 94 / 406 |
peripheral blood | 24% | 782.23 | 226 / 929 | 0% | 0 | 0 / 0 |
muscle | 8% | 28.15 | 62 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 5% | 0.45 | 4 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007622 | Biological process | rhythmic behavior |
GO_0016925 | Biological process | protein sumoylation |
GO_0021660 | Biological process | rhombomere 3 formation |
GO_0035904 | Biological process | aorta development |
GO_0014037 | Biological process | Schwann cell differentiation |
GO_0006611 | Biological process | protein export from nucleus |
GO_0042552 | Biological process | myelination |
GO_0007611 | Biological process | learning or memory |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0021666 | Biological process | rhombomere 5 formation |
GO_0032868 | Biological process | response to insulin |
GO_0014040 | Biological process | positive regulation of Schwann cell differentiation |
GO_0021612 | Biological process | facial nerve structural organization |
GO_0048168 | Biological process | regulation of neuronal synaptic plasticity |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0007422 | Biological process | peripheral nervous system development |
GO_0021659 | Biological process | rhombomere 3 structural organization |
GO_0007420 | Biological process | brain development |
GO_0008045 | Biological process | motor neuron axon guidance |
GO_0010467 | Biological process | gene expression |
GO_0031643 | Biological process | positive regulation of myelination |
GO_0035914 | Biological process | skeletal muscle cell differentiation |
GO_0035284 | Biological process | brain segmentation |
GO_0021665 | Biological process | rhombomere 5 structural organization |
GO_0030278 | Biological process | regulation of ossification |
GO_0045444 | Biological process | fat cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0061665 | Molecular function | SUMO ligase activity |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0071837 | Molecular function | HMG box domain binding |
Gene name | EGR2 |
Protein name | E3 SUMO-protein ligase EGR2 (E3 SUMO-protein transferase ERG2) (Early growth response protein 2) Early growth response 2 isoform 1 Early growth response 2 E3 SUMO-protein ligase EGR2 (EC 2.3.2.-) (AT591) (E3 SUMO-protein transferase ERG2) (Early growth response protein 2) (EGR-2) (Zinc finger protein Krox-20) E3 SUMO-protein ligase EGR2 |
Synonyms | KROX20 |
Description | FUNCTION: Sequence-specific DNA-binding transcription factor . Plays a role in hindbrain segmentation by regulating the expression of a subset of homeobox containing genes and in Schwann cell myelination by regulating the expression of genes involved in the formation and maintenance of myelin (By similarity). Binds to two EGR2-consensus sites EGR2A (5'-CTGTAGGAG-3') and EGR2B (5'-ATGTAGGTG-3') in the HOXB3 enhancer and promotes HOXB3 transcriptional activation (By similarity). Binds to specific DNA sites located in the promoter region of HOXA4, HOXB2 and ERBB2 (By similarity). Regulates hindbrain segmentation by controlling the expression of Hox genes, such as HOXA4, HOXB3 and HOXB2, and thereby specifying odd and even rhombomeres (By similarity). Promotes the expression of HOXB3 in the rhombomere r5 in the hindbrain (By similarity). Regulates myelination in the peripheral nervous system after birth, possibly by regulating the expression of myelin proteins, such as MPZ, and by promoting the differentiation of Schwann cells (By similarity). Involved in the development of the jaw openener musculature, probably by playing a role in its innervation through trigeminal motor neurons (By similarity). May play a role in adipogenesis, possibly by regulating the expression of CEBPB (By similarity). .; FUNCTION: E3 SUMO-protein ligase helping SUMO1 conjugation to its coregulators NAB1 and NAB2, whose sumoylation down-regulates EGR2 transcriptional activity. . FUNCTION: E3 SUMO-protein ligase helping SUMO1 conjugation to its coregulators NAB1 and NAB2, whose sumoylation down-regulates EGR2 transcriptional activity. . FUNCTION: E3 SUMO-protein ligase helping SUMO1 conjugation to its coregulators NAB1 and NAB2, whose sumoylation down-regulates EGR2 transcriptional activity. . |
Accessions | ENST00000690143.1 A0A8I5QL03 A0A0S2Z3U4 A0A8I5KVU0 A0A8I5KYI5 ENST00000411732.4 [P11161-2] ENST00000691610.1 ENST00000439032.6 ENST00000637191.2 [P11161-1] A0A0S2Z3Q5 ENST00000637191 ENST00000242480.4 [P11161-1] A0A1B0GUL0 P11161 |